News

Search:  

Latest News | 17 May 2012

Committee Calls for Improved Pharmacovigilance, New Labeling Requirements in Europe

2 Likes

The European Parliament’s Environment, Public Health and Food Safety Committee (ENVI) is calling for new methods to monitor, label and withdraw dangerous medicines on an EU-wide basis.Under new [Read More...]


Latest News | 4 May 2012

EMA Adopts Guidance on Medical Products Containing Genetically Modified Cells

0 Likes

The European Medicines Agency (EMA) announced 5 May it has adopted a scientific guideline on aspects relating to the development and testing of medicinal products containing genetically modified [Read More...]


Latest News | 24 April 2012

FDA Releases Strategic Plan for Veterinary Medicine Program

0 Likes

The US Food and Drug Administration (FDA) has released a new strategic plan for its veterinary medicine program for the 2012-2016 period, outlining the regulatory goals for FDA’s Center for Veterinary [Read More...]


Latest News | 5 April 2012

EMA Asks for Feedback on Pharmacovigilance Legislation Implementation

0 Likes

The European Medicines Agency (EMA) is calling on industry to comment on its draft list of European Union reference dates for Period Safety Update Reports (PSURs) that are being implemented as a [Read More...]


Latest News | 2 April 2012

EMA Releases Presentations, Videos from Pharmacovigilance Stakeholder Meeting

0 Likes

The European Medicines Agency (EMA) today (2 April) released video and presentations from its fourth stakeholder forum on the implementation of the new pharmacovigilance legislation. The meeting was [Read More...]


Latest News | 26 March 2012

EMA Strengthens Conflict of Interest Policies

0 Likes

The European Medicines Agency (EMA) announced Monday, 26 March its Management Board has endorsed a proposal from EMA Executive Director Guido Rasi to strengthen conflict of interest policies [Read More...]


Latest News | 1 March 2012

EMA Releases Guideline on Pharmacovigilance Plan Submissions

0 Likes

The European Medicines Agency (EMA) released guidance 29 February on how Marketing Authorization Holders (MAH) can submit pharmacovigilance (PhV) systems as part of their Marketing Authorization [Read More...]


Latest News | 22 February 2012

EMA to Focus on Pharmacovigilance, Counterfeiting

0 Likes

According to a report by PMLIVE Intelligence Online, the European Medicines Agency (EMA) is setting its sights on new pharmacovigilance laws and fighting counterfeit medicines. The goals are outlined [Read More...]


Latest News | 2 February 2012

EMA Prepares for ‘Biggest Change’ to Legal Framework Since Founding

0 Likes

The European Medicines Agency (EMA) announced on 2 February that it “is preparing for the introduction of the new pharmacovigilance legislation in July this year, which will bring the biggest change [Read More...]


Latest News | 24 January 2012

EMA Calls for Guidelines on the Use of Pharmacogenomics in Pharmacovigilance Evaluation

0 Likes

The European Medicines Agency (EMA) issued a concept paper on 23 January that calls for a new guideline to be issued on the use of pharmacogenomics in the conduct of pharmacovigilance.The concept [Read More...]


1 2